v3.26.3
Organization and Summary of Significant Accounting Policies - (Additional Information) (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Jun. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Nov. 30, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Exercise price of warrants                   $ 100
Net loss $ (30,687) $ (30,159) $ (31,213) $ (32,250) $ (34,070) $ (37,621) $ (92,059) $ (103,941)    
Net cash used in operating activities (27,800)           $ (82,149) $ (82,770)    
Anti-dilutive securities (in shares)             36,510,425 33,019,922    
Letter of credit reduction             $ 5,000      
Operating Expenses 32,247     $ 36,476     99,762 $ 118,260    
Accumulated deficit (1,626,368)           (1,626,368)   $ (1,534,309)  
Cash equivalents and short-term investments $ 139,100           $ 139,100      
Restricted Stock Units (RSUs)                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Anti-dilutive securities (in shares)             6,611,125 6,647,093    
Class A Convertible Preferred Stock                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Anti-dilutive securities (in shares)             13,775,430 13,775,430    
Common Stock [Member]                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Issuance of common stock from ATM offering, net of commissions and issuance costs (Shares) 2,801,602